Cross-species study shows that Type 2 diabetes drug metformin could change the way childhood brain injury is treated
Discovery to provide insights into liver development and disease progression
Medicine by Design is expanding its regenerative medicine research portfolio with the addition of four multi-disciplinary, multi-institution projects. “These team projects build on Medicine by Design’s successes over its first three years and will strengthen the University of Toronto and its affiliated hospitals as a global centre for regenerative medicine,” said Michael Sefton, executive director of Medicine by Design.
